In infected cells, human herpes simplex virus (HSV) can cause either lytic or latent infection. During lytic infection, the viral regulatory protein VP16 (also referred to as Vmw65, ␣-TIF, and ICP25) forms a multiprotein-DNA complex with two cellular proteins: the POU homeodomain transcription factor Oct-1 and the cell proliferation factor HCF. VP16 first associates with HCF (also referred to as C1, VCAF, and CFF) to form a stable DNA-independent heterodimeric complex. VP16 binding to HCF facilitates its subsequent association with Oct-1 on VP16-responsive cis-regulatory TAATGARAT (R, purine) elements in the HSV immediate-early promoters, initiating a cascade of viral gene expression (for reviews, see references 22, 28, and 31) .
Human HCF consists of a complex of noncovalently associated polypeptides ranging from 110 to 150 kDa (15, 16, 30, 32) . These associated polypeptides are derived from a large precursor protein of over 2,000 amino acids by specific proteolytic cleavage at a series of six centrally located 26-amino acid repeats, referred to here as HCF PRO repeats (15, 30, 32) . The function of the carboxy-terminal fragments is not known. Within the amino-terminal fragments, however, the aminoterminal 380 residues are sufficient to bind VP16, stabilize the VP16-induced complex with Oct-1, and activate transcription in vivo (17, 33) . This region of HCF, called the HCF VIC domain, contains six sequence repeats related to "kelch" repeats found in the Drosophila egg chamber protein kelch (34) . These repeats, called HCF KEL repeats, are both necessary and sufficient for efficient complex formation with VP16 (33) . Among mammalian HCFs, both sets of repeats, HCF PRO and HCF KEL , are highly conserved (8, 13, 30) .
In addition to its role in HSV gene expression, HCF is required for cell proliferation. A single missense mutation in the hamster cell line tsBN67, a proline-to-serine substitution at position 134 (P134S) of HCF, causes a temperature-sensitive defect in cell proliferation (8) and disrupts interaction with VP16 (33) . Consistent with an involvement in cell proliferation, human HCF is expressed in proliferating cultured cells and embryonic tissues (13, 29) .
HCF may have been conserved during metazoan evolution, because extracts from Spodoptera and Drosophila insect cells, but not yeast, can stabilize VP16 association with human Oct-1 (14, 31) . We show here that the nematode Caenorhabditis elegans expresses a functional homolog of human HCF. Although C. elegans HCF lacks some sequence elements important for human HCF function, the C. elegans HCF homolog can support mammalian cell proliferation, suggesting that HCF plays a highly conserved role in metazoan cell proliferation.
MATERIALS AND METHODS
Extract preparation and electrophoretic mobility retardation analysis. Wildtype Bristol N2 strain C. elegans worms were grown as previously described (4) . All worms were grown at 20°C. Worms were freed of bacteria (18) and collected, and worm pellets were suspended in 10 mM HEPES (pH 7.6) containing 10 mM KCl, 5 mM MgCl 2 , 0.1 mM EDTA, 0.5 mM EGTA, 10 mM benzamidine, 1 mM Na metabisulfite, 2 g of leupeptin/ml, and 2 g of aprotinin/ml. The worm suspension was passed through a French press at 1,500 psi. The homogenate was then centrifuged at 85,000 ϫ g for 30 min at 4°C. The supernatant solution was taken as total cell extract. About 2 g of cell extract (about 1 to 3 g/l) was used for electrophoretic mobility retardation analysis. Human HCF was purified by immunoprecipitation with amino-terminal ␣HCF N18 antipeptide antisera (8) and elution with the HCF N18 peptide. The Oct-1 POU domain and VP16 lacking its transcriptional activation domain (VP16⌬C) were prepared for VP16-induced complex formation as glutathione S-transferase (GST) fusion proteins. The proteins were expressed and purified from Escherichia coli as previously described (30, 33) ; the Oct-1 POU domain, but not VP16⌬C, was separated from the GST moiety by treatment with thrombin. Electrophoretic mobility retardation analysis was performed with the (OCTA ϩ )TAATGARAT probe as previously described (30) .
C. elegans hcf-1 cDNA isolation and in vitro protein expression. The amino acid sequence of the human HCF VIC domain (residues 1 to 380) was used to search the C. elegans Sanger Center Network database (26) with TBLASTN (2). Significant sequence similarity to a predicted gene present on the overlapping cosmids C33H5 and C46A5 was found. A cDNA copy of this gene was prepared by PCR with oligonucleotides containing C. elegans sequence corresponding to predicted initiation (ATGGACGAAGATGTCGGTTTAG) and termination (TTACTGATGATCGAAACGAGCTC) codons (underlined) and a mixedstage C. elegans cDNA library (a kind gift of R. Barstead, Oklahoma Medical Research Foundation). A 2.4-kb DNA fragment was amplified and isolated for sequence analysis and subcloning. Sequences encoding the full-length (782 residues) and the amino-terminal 395 amino acids of C. elegans HCF were cloned into the in vitro transcription and translation expression plasmid pNCITE as previously described (33 performed with the TNT system (Promega, Inc.). The anti-C. elegans HCF antiserum ␣CeHCF N16 was raised in rabbits against a 17-amino-acid peptide containing the 16 amino-terminal residues of C. elegans HCF (MDEDVGLEA TNYSRGDC) (underlined) coupled to keyhole limpet hemocyanin via the carboxy-terminal cysteine residue as previously described (10) .
Synchronization of C. elegans, extract preparation, and Northern hybridization analysis. Viable Bristol N2 strain C. elegans embryos were prepared by treating a mixed population of worms with alkaline hypochlorite (11) . The embryos were synchronized by letting the worms hatch in the absence of nutrients at 20°C overnight. The hatched worms were subsequently transferred to NGM plates with E. coli OP50 as a food source. L1-stage worms were harvested 6 h after feeding; the harvesting times (hours) after feeding for worms at other stages were as follows: L2, 20; L3, 29; L4, 40 h. Young adult worms were harvested 52 h after feeding (18) . The stage of worm development was verified by microscopic examination. Protein extracts were prepared and electrophoretic mobility retardation analyses were performed as described above. RNA extracts were prepared from cleaned worms by freezing the pelleted worms in liquid nitrogen and grinding them into a powder in a mortar for total RNA preparation as previously described (12) . Twenty-five micrograms of total RNA was used to perform Northern hybridization analysis as previously described (23) with 32 Plabeled, random-primed DNA fragments corresponding to full-length C. elegans hcf-1 as the probe.
Mammalian-cell HCF expression vectors and rescue of the tsBN67 temperature-sensitive defect. The human HCF expression constructs pCGNHCF FL , pCGNHCF N1011 , and pCGNHCF N380 have been described previously (30, 33) . The C. elegans HCF expression constructs pCGNCeHCF FL and pCGNCeH-CF N395 contain coding sequences corresponding to full-length HCF and the amino-terminal 395 residues of CeHCF, respectively, in the cytomegalovirus promoter and hemagglutinin epitope-tagged expression construct pCGN (30) . Rescue of the tsBN67 temperature-sensitive defect was performed as described previously (8) . tsBN67 cells were seeded at 2 ϫ 10 5 cells/100-mm-diameter dish and cultured in Dulbecco's modified Eagle medium supplemented with 10% fetal bovine serum at permissive temperature (33.5°C) for 20 h prior to transfection. Expression constructs for human or C. elegans HCF (2 g/dish) were then cotransfected by calcium-phosphate coprecipitation with the plasmid pSV2neo (0.5 g/dish) into tsBN67 cells (5) . Following transfection, the cells were incubated at 33.5°C for 20 h, washed with serum-free medium, and incubated at 33.5°C for an additional 24 h before selection for 2 weeks at the nonpermissive temperature of 39.5°C in the presence of G418 (0.8 mg/ml). Colonies were identified by fixation and staining with crystal violet.
Nucleotide sequence accession number. The GenBank accession number for the C. elegans HCF sequence is AF072907.
RESULTS

VP16
-induced complex-forming activity in C. elegans extracts. Analyses of insect cells have revealed an activity capable of stabilizing VP16 association with human Oct-1, suggesting the existence of an HCF homolog in insects (14, 31) . To determine whether such an activity is generally present in metazoans, we asked whether extracts from the nematode C. elegans can also stabilize VP16 association with human Oct-1, as shown in Fig. 1 . We prepared cell extract from mixed-stage worms and compared the VP16-induced complex formation of this extract with that of purified human HCF by using an electrophoretic mobility retardation assay with an HSV TAA TGARAT site. The TAATGARAT site, an (OCTA ϩ )TAAT GARAT site, contained the octamer sequence ATGCTAAT, which serves as a binding site for Oct-1. For this assay, we used VP16 lacking its transcriptional-activation domain and the human Oct-1 DNA-binding POU domain expressed and purified from E. coli. In the absence of human HCF or C. elegans extract, the Oct-1 POU domain, but not VP16, bound DNA on its own (Fig. 1, cf. lanes 1 to 3) . Together, the Oct-1 POU domain and VP16 formed a low level of HCF-independent VP16-induced complex (Fig. 1, lane 4) . Addition of purified human HCF (lane 5) did not result in any new complexes, whereas addition of the C. elegans extract alone resulted in a low level of a novel complex (lane 6), for which we do not know the identity. Addition of human HCF or C. elegans extract to either the Oct-1 POU domain or VP16 resulted in superimposition of the individual patterns of complex formation (Fig. 1 , cf. lanes 2 and 3 and lanes 5 to 10). However, addition of either the human HCF preparation or the C. elegans extract together with VP16 to the Oct-1 POU domain induced novel VP16-induced complexes (cf. lanes 11 and 12 with lanes 7 and 8). These results suggest that C. elegans worms contain an activity that can replace human HCF in stabilizing the VP16-induced complex.
The mobility of the C. elegans VP16-induced complex (Ce VIC) is between that of the HCF-independent VP16-induced complex and that of the human HCF VP16-induced complex (Hu VIC) ( Fig. 1 ), suggesting that a C. elegans protein of a different size from that of human HCF, probably smaller, is incorporated into the C. elegans VP16-induced complex. A similar analysis of insect extracts suggested that insect HCFs are also smaller than human HCF (31); direct comparison of VP16-induced complexes stabilized by insect and C. elegans extracts suggests that the C. elegans HCF-like protein is smaller than its insect counterparts (28a).
Functional C. elegans HCF homolog. The surprising finding that invertebrate cell extracts can stabilize association of a viral protein with a human transcription factor (i.e., VP16 with Oct-1) (this study and references 14 and 31), prompted us to search the C. elegans genome sequence for human HCF VIC domain-related sequences. This search, however, was hampered by the general similarity of the HCF VIC domain to kelch repeat-containing proteins. For example, in our first attempt to identify a C. elegans HCF homolog, we identified sequence similarity to the predicted C. elegans gene F33C8.1 (Q19981), a kelch repeat-containing gene. The product of this gene, however, failed to stabilize the VP16-induced complex (data not shown).
Subsequent determination of the C. elegans genome sequence revealed a sequence on C. elegans chromosome IV which was related to both the amino-and carboxy-terminal regions of human HCF. This sequence similarity has also been noted by others (13, 17) . The predicted coding sequence for this gene presented in the database and reproduced in these published studies (13, 17) does not, however, reveal similarity to the entire region of human HCF that is required for stabilization of the VP16-induced complex (i.e., the HCF VIC domain) (33) . Further examination of the C. elegans genomic sequence neighboring this gene revealed possible exons that would provide similarity to the entire human HCF VIC domain.
Encouraged by this observation, we designed primers that we predicted would match the translational initiation and stop codons of the C. elegans HCF gene and used them for PCR with a C. elegans cDNA library. A cDNA thus isolated revealed sequence similarity to the human HCF gene across the entire HCF VIC domain-coding sequences. Further PCR analysis showed that the transcript from this gene contains a transspliced SL1 leader sequence positioned five nucleotides upstream of the predicted initiation codon (data not shown). Figure 2 shows a comparison of the amino-acid sequence of this C. elegans HCF-related protein with that of human HCF. In contrast to human HCF, which is approximately 2,000 amino acids long, the predicted C. elegans protein contains only 782 amino acids, in which the amino-and carboxy-terminal regions of human HCF are highly conserved. As illustrated in Fig. 2B , the amino-terminal HCF VIC domain of human HCF is 54% identical to the corresponding region of the C. elegans HCF-related protein and the carboxy-terminal 230 amino acids of human HCF are 49% identical to the carboxy-terminal region of the C. elegans protein (see also VOL. 19, 1999 C. ELEGANS HCFity to the basic and acidic regions in human HCF. Significantly, as noted previously (13, 17) , this C. elegans protein contains no evident similarity to the human HCF PRO repeats required for HCF processing in human cells (32) . This comparison suggests that, if this protein is the functional C. elegans homolog of human HCF, C. elegans HCF either is not processed or is processed by a different mechanism.
To determine whether the C. elegans HCF-related protein is functionally related to human HCF, we assayed the ability of this protein to stabilize the VP16-induced complex by using an electrophoretic mobility retardation assay as shown in Fig. 3 . To compare the activities of the human and C. elegans proteins, we synthesized the HCF VIC domain of human HCF and the full-length HCF protein and putative HCF VIC domain of C. elegans by in vitro translation. The in vitro translation extract used for this experiment generated a low level of contaminating complex in the electrophoretic mobility retardation assay (Fig. 3, cf. lane 3 with lanes 1 and 2) . Consistent with previous results (17, 33) , the wild-type human HCF VIC domain (lane 4) but not the mutant human HCF VIC domain carrying the tsBN67 P134S mutation (Fig. 3, lane 5 ) directed formation of a prominent VP16-induced complex, referred to as Hu mini-VIC. The full-length C. elegans protein synthesized in vitro also directed VP16-induced complex formation (Fig. 3, lane 6) ; this complex comigrates with the VP16-induced complex generated by C. elegans extract (data not shown). Sensitivity of the C. elegans VP16-induced complex to antisera directed against the amino terminus of the predicted C. elegans protein sequence (Fig. 3, lane 8) but not to the corresponding preimmune antisera (lane 7) indicates that, as with the human protein, the C. elegans protein was incorporated into the VP16-induced complex. These results suggest that this C. elegans HCF-related protein is a functional homolog of human HCF. Following the convention of the C. elegans research community, we designate this protein HCF-1 and its cognate gene hcf-1. Here, however, we refer to HCF-1 as C. elegans HCF or CeHCF.
Consistent with the observed functional relationship between the C. elegans and human HCF proteins, the proline that is changed to a serine in the temperature-sensitive tsBN67 mutation is conserved in the C. elegans HCF protein ( Fig. 2A) . To determine whether a mutation in C. elegans HCF which is analogous to the hamster tsBN67 mutation also disrupts VP16-induced complex formation, we engineered the proline-toserine mutation into the corresponding position (residue 145) of full-length C. elegans HCF (P145S). As in human and hamster HCF (8, 33) , this tsBN67 proline-to-serine point mutation disrupts VP16-induced complex formation (Fig. 3 , cf. lanes 9 and 6).
We also assayed the ability of the region of C. elegans HCF corresponding to the human HCF VIC domain (CeHCF residues 1 to 395 [CeHCF N395 ]) to stabilize the VP16-induced complex. Curiously, although CeHCF N395 stabilized the VP16-induced complex (Fig. 3, lane 10) , it did so less efficiently than either the human HCF VIC domain or the full-length CeHCF (Fig. 3, cf. lanes 4, 6, and 10) . Thus, the C. elegans HCF region that contributes to stabilization of the VP16-induced complex may extend beyond the HCF KEL -repeat region.
Developmental regulation of HCF expression in C. elegans. Southern hybridization analysis using the cloned C. elegans hcf-1 cDNA as probe demonstrated that there is a single copy of the hcf-1 gene in the C. elegans genome (data not shown). To reveal the expression of hcf-1 during development, worms were synchronized by embryo isolation and subsequent collection of worms at the embryonic, L1 to L4 larval, and gravid elegans worms were synchronized as described in Materials and Methods. Total RNAs were isolated from embryos; L1, L2, L3, and L4 larvae; and adults. RNAs were probed by Northern hybridization analysis using labeled hcf-1 cDNA as a probe. The levels of total RNA in each lane were assayed by staining the 18S rRNA with ethidium bromide as shown at the bottom.
(embryo-containing adults) developmental stages. Total RNA was isolated and probed for hcf-1 mRNA expression by Northern hybridization analysis as shown in Fig. 4 . This analysis revealed a single hcf-1 mRNA of 2.6 kb expressed primarily in embryos and adults (Fig. 4 , cf. lanes 1 and 6 with the larval stages in lanes 2 to 5). The embryonic expression parallels the embryonic expression of human HCF mRNA (13, 29) . The adult expression may represent either adult cell expression (i.e., somatic or germline) or expression in the embryos present in gravid adults; we have not distinguished between these possibilities.
We also assayed the abilities of extracts from C. elegans at different stages of development to stabilize the VP16-induced complex. We prepared cell extracts from worms at different developmental stages and assayed their abilities to support VP16-induced complex formation by using an electrophoretic mobility retardation assay as shown in Fig. 5 . As with the hcf-1 mRNA, CeHCF activity was observed in extracts from embryos and adult worms (Fig. 5, lanes 3 and 8) but not in extracts from larvae (lanes 4 to 7). The authenticity of the observed complex with the embryo extract was confirmed by use of the antisera directed against the amino terminus of the predicted C. elegans protein sequence (␣HCF) and preimmune antisera (Fig. 5, lanes 9 and 10) , which shows that the predicted aminoterminal sequence presented in Fig. 2 is correct. Thus, during C. elegans development, VP16-induced complex-forming activity correlates with hcf-1 gene expression.
Rescue of the tsBN67 cell proliferation defect by CeHCF. The studies described above demonstrate that the ability of HCF to stabilize the VP16-induced complex has been conserved during metazoan evolution ( Fig. 1 and 3) . Therefore, we asked whether the ability of HCF to promote cell proliferation has also been conserved. A priori, examination of the C. elegans HCF sequence would suggest that the C. elegans HCF protein cannot overcome the hamster tsBN67 cell-proliferation defect because it lacks sequences corresponding to the basic region of human HCF (Fig. 2) ; in human HCF, the basic region sequences are required to rescue the tsBN67 cell proliferation defect (33) . Nevertheless, to test the ability of C. elegans HCF to promote mammalian cell proliferation, we transfected tsBN67 cells with mammalian CeHCF expression vectors and assayed the transfected cells for colony formation at a nonpermissive temperature as shown in Fig. 6 . Analysis of protein expression in a separate short-term assay showed that all of the proteins assayed are faithfully expressed (data not shown).
Full-length human HCF rescued the tsBN67 defect in this assay (Fig. 6 , cf. plates 5 and 1) as described previously (8, 33) . Also consistent with the results of previous studies (33), the amino-terminal half of human HCF (HuHCF N1011 ) rescued the temperature-sensitive cell proliferation defect better than full-length HCF (Fig. 6 , cf. plates 4 and 5), whereas just the HCF VIC domain (HuHCF N380 ) lacking the basic region failed to rescue the defect (cf. plates 1 and 2). To our surprise, full-length C. elegans HCF complemented the tsBN67 defect even though it lacks a conserved basic region (cf. plates 1 and 6). Thus, a role for HCF in cell proliferation has been conserved during metazoan evolution, but interestingly, this role is not dependent on conservation of a basic region.
Further, to our surprise and in stark contrast to the results obtained with the human protein, the region of C. elegans HCF corresponding to the human HCF VIC domain (CeHCF N395 ) complemented the tsBN67 defect nearly as well as the fulllength C. elegans HCF protein (Fig. 6 , cf. plates 3 and 6) and better than its human HCF VIC domain counterpart (cf. plates 2 and 3). This result explains why C. elegans HCF can rescue the tsBN67 defect even though it lacks an evident basic region. It also suggests that, while the cellular function of HCF has been conserved during metazoan evolution, the relative roles of different regions of HCF in promoting cell proliferation have changed: in human HCF, the HCF VIC domain cooperates with the neighboring basic region to promote cell proliferation, whereas in C. elegans, the region corresponding to the human HCF VIC domain can promote cell proliferation on its own.
DISCUSSION
Through identification and characterization of a functional homolog of mammalian HCF in C. elegans we have shown that selected sequences and functions of HCF have been conserved in metazoans.
Uneven HCF sequence conservation during metazoan evolution. The complete sequence of C. elegans HCF reveals a striking pattern of sequence conservation: the amino-and carboxy-terminal regions of HCF are highly conserved, but as noted previously (13, 17) , the central regions, including the HCF PRO repeats required for human HCF processing (32) , are poorly conserved (Fig. 2) . When the sequence of human HCF was first identified, there was no known sequence relationship to other proteins, but it was noted that both the amino-terminal and carboxy-terminal regions are enriched in charged and large hydrophobic residues (Charged/WYF [30] ). We now know that the amino-terminal Charged/WYF region is the HCF VIC domain (17, 33) and is also involved in cell proliferation (8) . Although implicated in stabilization of a VP16-induced complex with full-length VP16 (17) , the cellular function of the carboxy-terminal Charged/WYF region remains unknown. Its high level of conservation in C. elegans suggests that, like its amino-terminal counterpart, it also plays an important role in HCF function, perhaps also in cell proliferation.
The lack of conservation of the central region of mammalian HCF in a functional homolog of this protein in C. elegans has important implications for our understanding of the evolution of HCF. For example, the lack of HCF PRO repeats in C. elegans HCF suggests that in C. elegans HCF processing is not essential for the function of the conserved amino-and carboxyterminal regions of HCF. A priori, we imagined two potential structures for a functional homolog(s) of HCF in distantly related species: (i) the HCF PRO repeats and processing would be conserved, or (ii) the HCF PRO repeats would be lost and the amino-and carboxy-terminal regions would be encoded by separate genes. Instead, in C. elegans HCF, the HCF PRO repeats have been lost but the amino-and carboxy-terminal regions remain part of a single gene. These results make the purpose of HCF processing a continuing enigma. We suspect that mammalian HCF processing and controlled association of the resulting fragments provide mammalian HCF greater versatility in its cellular function such as in the control of cell proliferation.
The other region of human HCF of known function but not conserved in C. elegans HCF is the basic region between the HCF VIC domain and the HCF PRO repeats (Fig. 2) . In human HCF, the basic region, together with the HCF VIC domain, is required to rescue the tsBN67 cell proliferation defect (33) . Because of the lack of a corresponding basic region in C.
elegans HCF, we were surprised to find that C. elegans HCF can rescue the tsBN67 defect. C. elegans HCF rescues the tsBN67 phenotype because its HCF VIC -like domain is more potent than its human counterpart in rescuing the tsBN67 phenotype (Fig. 6, panels 2 and 3) . Thus, in certain respects, the distantly related C. elegans HCF protein functions better than the human protein in mammalian cells. Perhaps, in human HCF, the HCF VIC domain and the basic region cooperate to promote cell proliferation, whereas in C. elegans HCF, the HCF VIC -like region can drive cells through the cell cycle independently of a basic region. Curiously, however, although the C. elegans HCF VIC -like region is more potent for rescue of the tsBN67 cell proliferation defect, it is less effective for stabilization of the VP16-induced complex (Fig. 3) . We do not know the reason for this difference.
The smaller size of C. elegans HCF compared to that of human HCF demonstrates that HCFs can differ considerably in size. This flexibility may explain the nature of the C1 and C2 VP16-induced complexes described by Kristie and colleagues (14) using VP16 purified from Spodoptera cells after baculovirus expression. We suggest that the faster-migrating complex called C1 in that study contained Spodoptera HCF (or in some cases possibly amino-terminal fragments of human HCF) and the C2 complex contained full-length human HCF.
The viral protein VP16 targets a cellular protein that is highly conserved in metazoans. VP16 is a viral protein of the human pathogen HSV. Thus, the ability of VP16 to associate with HCF from animals as distantly related to humans as C. elegans probably results because VP16 binds to a surface of HCF that is used in a cellular function conserved during metazoan evolution. We hypothesize that this conserved cellular function of HCF is its association with the basic leucine zipper protein, LZIP. LZIP, also known as Luman (19) , binds HCF as VP16 does, and LZIP and VP16 share a tetrapeptide motif FIG. 6 . CeHCF rescues the hamster tsBN67 cell proliferation defect. Hamster tsBN67 cells were transfected with the human pCGNHCF or C. elegans pCGNCe-HCF HCF expression construct as described in Materials and Methods. Plate 1, pCGN vector alone; plate 2, pCGNHCF N380 ; plate 3, pCGNCeHCF N395 ; plate 4, pCGNHCF N1011 ; plate 5, pCGNHCF FL ; plate 6, pCGNCeHCF FL . Following the transfection protocol, the cells were incubated at 39.5°C in the presence of G418 for 2 weeks. The colonies were then fixed and stained with crystal violet.
( E / D HxY) that directs association with HCF (7, 20) . Like HCF, LZIP has been conserved during metazoan evolution. In Drosophila melanogaster, the LZIP homolog is BBF-2/dCREB-A (1, 24), which also possesses an E / D HxY motif that directs association with HCF (7, 20) . Thus, in its association with HCF, VP16 probably mimics how LZIP binds HCF. Together with the studies described here, these observations suggest that C. elegans probably also possesses a functional LZIP homolog, although its identity has yet to be determined. In contrast to the high level of conservation of the HCF surface that directs association with VP16, the surface of Oct-1 that directs association with VP16 has not been highly conserved. Indeed, owing to differences on the VP16-interaction surface of the mouse Oct-1 homeodomain, VP16 fails to associate effectively with mouse Oct-1 (6, 27) . Thus, apparently the VP16-interaction surface of Oct-1 is less important for Oct-1 cellular function than the VP16-interaction surface of HCF is for HCF cellular function. Consistent with this hypothesis, VP16 is not known to mimic a cellular factor in its interaction with Oct-1. Indeed, just the opposite, a cellular factor that is known to interact with the Oct-1 homeodomain, the B-cell Oct-1 coregulator OCA-B (9, 21, 25) , interacts with a different surface of the Oct-1 homeodomain than does VP16 (3).
VP16 targets a conserved cell proliferation function to control HSV infection. One of the curiosities of HSV infection is that the viral transactivator VP16 requires association with two cellular proteins to activate viral gene expression. We have hypothesized that the requirement for productive association with cellular proteins serves as a checkpoint to gauge whether the state of the infected cell is appropriate for productive lytic infection (30) . The results described here suggest that, in its association with HCF, VP16 targets a protein with an ancient role in cell proliferation. This association may serve as a mechanism to link HSV infection to the cell cycle status of the infected cell.
